Cite
HARVARD Citation
Jerzak, K. et al. (n.d.). Cetuximab plus irinotecan versus panitumumab in patients with refractory metastatic colorectal cancer in Ontario, Canada. International journal of cancer. 140 (9), pp. 2162-2167. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jerzak, K. et al. (n.d.). Cetuximab plus irinotecan versus panitumumab in patients with refractory metastatic colorectal cancer in Ontario, Canada. International journal of cancer. 140 (9), pp. 2162-2167. [Online].